Agios Pharm (AGIO) had the highest return between August 23, 2014 and December 18, 2014 by a mid-cap US stock, returning 172.5%.
| ASSET | DATE | % RETURN |
|---|---|---|
Agios Pharm (AGIO) | 8/23/2014 - 12/18/2014 | 172.46% |
TG Therapeutics (TGTX) | 8/23/2014 - 12/18/2014 | 91.93% |
PTC Therapeutics (PTCT) | 8/23/2014 - 12/18/2014 | 80.14% |
Leonardo DRS, Inc Common Stock (DRS) | 8/23/2014 - 12/18/2014 | 71.43% |
Ionis Pharmaceuticals (IONS) | 8/23/2014 - 12/18/2014 | 71.07% |
Vicor (VICR) | 8/23/2014 - 12/18/2014 | 66.24% |
Xenon Pharmaceuticals (XENE) | 8/23/2014 - 12/18/2014 | 59.78% |
Cimpress (CMPR) | 8/23/2014 - 12/18/2014 | 58.38% |
Paycom Software (PAYC) | 8/23/2014 - 12/18/2014 | 57.15% |
Ambarella (AMBA) | 8/23/2014 - 12/18/2014 | 51.75% |
Magnite (MGNI) | 8/23/2014 - 12/18/2014 | 49.23% |
Qualys (QLYS) | 8/23/2014 - 12/18/2014 | 48.12% |
ACADIA Pharmaceuticals (ACAD) | 8/23/2014 - 12/18/2014 | 45.81% |
Seaboard (SEB) | 8/23/2014 - 12/18/2014 | 42.99% |
Applied Digital (APLD) | 8/23/2014 - 12/18/2014 | 42.03% |
Uniqure (QURE) | 8/23/2014 - 12/18/2014 | 41.38% |
Merit Medical Systems (MMSI) | 8/23/2014 - 12/18/2014 | 38.23% |
Installed Building Products (IBP) | 8/23/2014 - 12/18/2014 | 37.51% |
Ocular Therapeutix (OCUL) | 8/23/2014 - 12/18/2014 | 37.45% |
Precigen (PGEN) | 8/23/2014 - 12/18/2014 | 37.05% |
Varonis Systems (VRNS) | 8/23/2014 - 12/18/2014 | 36.3% |
V2X (VVX) | 8/23/2014 - 12/18/2014 | 35.23% |
Norwegian Cruise Line (NCLH) | 8/23/2014 - 12/18/2014 | 35.11% |
ICU Medical (ICUI) | 8/23/2014 - 12/18/2014 | 34.62% |
Qorvo (QRVO) | 8/23/2014 - 12/18/2014 | 34.48% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.